Arsenic pill could replace IV for rare leukemia
Disease control
Completed
This study looked at how an oral liquid form of arsenic trioxide (SDK001) works in 12 people with acute promyelocytic leukemia (APL). Researchers compared it to the standard IV version and checked if food or calcium supplements change how the drug is absorbed. The goal was to fin…
Phase: PHASE1 • Sponsor: SDK Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 08:48 UTC